Compare Laboratory Corp. of America Holdings with Similar Stocks
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
10.99%
0%
10.99%
6 Months
5.6%
0%
5.6%
1 Year
11.3%
0%
11.3%
2 Years
26.68%
0%
26.68%
3 Years
11.59%
0%
11.59%
4 Years
16.72%
0%
16.72%
5 Years
42.96%
0%
42.96%
Laboratory Corp. of America Holdings for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
3.28%
EBIT Growth (5y)
-0.76%
EBIT to Interest (avg)
10.71
Debt to EBITDA (avg)
1.97
Net Debt to Equity (avg)
0.65
Sales to Capital Employed (avg)
0.94
Tax Ratio
21.92%
Dividend Payout Ratio
32.58%
Pledged Shares
0
Institutional Holding
100.00%
ROCE (avg)
15.08%
ROE (avg)
15.85%
Valuation key factors
Factor
Value
P/E Ratio
28
Industry P/E
Price to Book Value
2.56
EV to EBIT
23.34
EV to EBITDA
14.82
EV to Capital Employed
1.95
EV to Sales
2.02
PEG Ratio
NA
Dividend Yield
1.17%
ROCE (Latest)
8.34%
ROE (Latest)
9.28%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bullish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bullish
Bullish
Moving Averages
Mildly Bearish (Daily)
KST
Bearish
Bullish
Dow Theory
Mildly Bullish
Mildly Bullish
OBV
No Trend
No Trend
Shareholding Snapshot : Mar 2025
Shareholding Compare (%holding) 
Majority shareholders
Domestic Funds
Domestic Funds
Held in 153 Schemes (42.25%)
Foreign Institutions
Held by 341 Foreign Institutions (20.08%)
Strategic Entities with highest holding
Highest Public shareholder
Quarterly Results Snapshot (Consolidated) - Jun'25 - YoY
Jun'25
Jun'24
Change(%)
Net Sales
3,527.30
3,220.90
9.51%
Operating Profit (PBDIT) excl Other Income
568.90
463.30
22.79%
Interest
57.10
47.60
19.96%
Exceptional Items
-4.10
-11.60
64.66%
Consolidate Net Profit
238.30
205.60
15.90%
Operating Profit Margin (Excl OI)
113.00%
95.10%
1.79%
USD in Million.
Net Sales
YoY Growth in quarter ended Jun 2025 is 9.51% vs 6.17% in Jun 2024
Consolidated Net Profit
YoY Growth in quarter ended Jun 2025 is 15.90% vs 32.47% in Jun 2024
Annual Results Snapshot (Consolidated) - Dec'24
Dec'24
Dec'23
Change(%)
Net Sales
13,008.90
12,161.60
6.97%
Operating Profit (PBDIT) excl Other Income
2,037.90
1,704.60
19.55%
Interest
208.30
199.60
4.36%
Exceptional Items
-51.30
-398.10
87.11%
Consolidate Net Profit
747.10
380.40
96.40%
Operating Profit Margin (Excl OI)
87.50%
92.40%
-0.49%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2024 is 6.97% vs 2.51% in Dec 2023
Consolidated Net Profit
YoY Growth in year ended Dec 2024 is 96.40% vs -62.09% in Dec 2023
About Laboratory Corp. of America Holdings 
Laboratory Corp. of America Holdings
Miscellaneous
Laboratory Corporation of America Holdings is a life sciences company that is integrated in guiding patient care, providing clinical laboratory and end-to-end drug development services. The Company operates as a healthcare diagnostics company. The Company operates through two segments: LabCorp Diagnostics (LCD) and Covance Drug Development (CDD). The LCD segment is an independent clinical laboratory business, which offers menu of frequently requested and specialty testing through an integrated network of primary and specialty laboratories across the United States. The CDD segment offers drug development services, and provides a range of drug research and development (R&D) and market access services to biopharmaceutical companies and medical device companies across the world. It serves a range of customers, including managed care organizations (MCOs), biopharmaceutical companies, governmental agencies, physicians and other healthcare providers.
Company Coordinates 
Company Details
358 S MAIN ST , BURLINGTON NC : 27215-5837
Registrar Details






